MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

Search

Natera Inc

Închisă

SectorSănătate

179.11 3.42

Rezumat

Modificarea prețului

24h

Curent

Minim

171.79

Maxim

181.22

Indicatori cheie

By Trading Economics

Venit

-34M

-101M

Vânzări

45M

547M

Marjă de profit

-18.467

Angajați

4,424

EBITDA

-33M

-90M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+18.74% upside

Dividende

By Dow Jones

Următoarele câștiguri

23 oct. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

5.3B

24B

Deschiderea anterioară

175.69

Închiderea anterioară

179.11

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Natera Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 oct. 2025, 23:25 UTC

Principalele dinamici ale pieței

Salesforce Rises on New FY30 Financial Targets

15 oct. 2025, 18:52 UTC

Câștiguri
Principalele dinamici ale pieței

Prologis Shares Gain on Raised Outlook, Data Center Growth

15 oct. 2025, 18:30 UTC

Achiziții, Fuziuni, Preluări

Constellation Software to Buy U.K.'s Tecvia Holding

15 oct. 2025, 17:19 UTC

Achiziții, Fuziuni, Preluări

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15 oct. 2025, 17:11 UTC

Achiziții, Fuziuni, Preluări

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15 oct. 2025, 23:48 UTC

Market Talk

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15 oct. 2025, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 oct. 2025, 22:37 UTC

Market Talk

Economic Stars Are Aligning for RBA -- Market Talk

15 oct. 2025, 21:44 UTC

Câștiguri

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15 oct. 2025, 20:50 UTC

Market Talk
Câștiguri

Financial Services Roundup: Market Talk

15 oct. 2025, 20:44 UTC

Achiziții, Fuziuni, Preluări

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15 oct. 2025, 20:44 UTC

Achiziții, Fuziuni, Preluări

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15 oct. 2025, 20:43 UTC

Achiziții, Fuziuni, Preluări

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15 oct. 2025, 20:34 UTC

Câștiguri

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15 oct. 2025, 20:31 UTC

Achiziții, Fuziuni, Preluări

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15 oct. 2025, 20:17 UTC

Achiziții, Fuziuni, Preluări

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15 oct. 2025, 19:06 UTC

Câștiguri

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15 oct. 2025, 19:04 UTC

Market Talk

Oil Futures Post Back-to-Back Losses -- Market Talk

15 oct. 2025, 18:46 UTC

Market Talk

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15 oct. 2025, 18:23 UTC

Câștiguri

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15 oct. 2025, 17:37 UTC

Achiziții, Fuziuni, Preluări

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15 oct. 2025, 17:34 UTC

Market Talk

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15 oct. 2025, 16:57 UTC

Câștiguri

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15 oct. 2025, 16:51 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica Doesn't Disclose Financial Details

15 oct. 2025, 16:50 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15 oct. 2025, 16:49 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15 oct. 2025, 16:48 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15 oct. 2025, 16:48 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15 oct. 2025, 16:47 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica Buys Ikerian

15 oct. 2025, 16:34 UTC

Market Talk

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Comparație

Modificare preț

Natera Inc Așteptări

Obiectiv de preț

By TipRanks

18.74% sus

Prognoză pe 12 luni

Medie 205.19 USD  18.74%

Maxim 268 USD

Minim 175 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNatera Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

18 ratings

16

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

153.79 / N/ASuport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Natera Inc

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.
help-icon Live chat